Physician profile
Dena Y Li
NPI 1083671549
$1,272.30
in general payments reported to CMS, 2019-2025
13 companies · $269 in 2025
The $269 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2020: $164 · 2021: $123 · 2022: $315 · 2023: $122 · 2024: $179 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $569.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $458.31 | 2022-2025 | Ozempic, Rybelsus |
| Gilead Sciences, INC. | $171.60 | 2019-2023 | |
| Lilly USA, LLC | $141.90 | 2020-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2022 | |
| Exact Sciences Corporation | $117.72 | 2023-2025 | Cologuard Collection Kit |
| Intra-Sana Laboratories | $111.11 | 2024 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Amgen INC. | $30.04 | 2025 | Otezla, Repatha |
| Amarin Pharma, INC. | $27.67 | 2019 | |
| Abbvie INC. | $25.58 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $25.37 | 2019 | |
| Merck Sharp & Dohme LLC | $14.49 | 2020 | |
| Alexion Pharmaceuticals, INC. | $12.45 | 2020 | |
| Sanofi-Aventis U.S. LLC | $11.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dena Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.